Pacylex News has migrated to Newsroom. Click the link below to access the latest articles and press releases.
CEO CFO Magazine recently caught up with Pacylex CEO Michael Weickert. Read their interview here.
Pacylex: Targeting myristoylation to selectively kill cancer.
info@pacylex.com